Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in
microalgae-based, high-value nutrition and health products, today
announced the results of its 2010 Annual Meeting of Stockholders, held
September 1, 2010, in Waikoloa, HI.
The stockholders re-elected Gerald R. Cysewski , Michael A. Davis, Gregg
W. Robertson, David I. Rosenthal and John T. Waldron to the Board of
Directors.
The stockholders approved Restated Articles of Incorporation that were
amended for the purposes of streamlining certain provisions concerning
basic corporate functions, conforming to other governing regulations and
deleting unnecessary and outdated provisions.
The stockholders ratified the selection of Grant Thornton LLP as the
Companys independent registered public accounting firm for the fiscal
year ending March 31, 2011.
About Cyanotech Cyanotech Corporation, a world leader in
microalgae technology, produces BioAstin Natural Astaxanthin and
Hawaiian Spirulina Pacificaall natural, functional nutrients
that leverage our experience and reputation for quality, building
nutritional brands which promote health and well-being. Cyanotechs
Spirulina products offer complete nutrition, and augment energy and
immune response. They are FDA reviewed and accepted as Generally
Recognized as Safe (GRAS) for use in food products. BioAstins superior
antioxidant activity and ability to support and maintain a natural
anti-inflammatory response enhance skin, muscle and joint health. All
Cyanotech products are produced from microalgae grown at its 90-acre
facility in Kona, Hawaii using patented and proprietary technology.
Cyanotech distributes to nutritional supplement, nutraceutical and
cosmeceutical manufacturers and marketers in more than 54 countries
worldwide. Cyanotech was the first microalgae company in the
world to obtain quality management standards ISO 9001:2000 certification
andis GMP-certified by the Natural Products AssociationTM.
Visit www.cyanotech.com
for more information.
Source: Business Wire
